
## Acknowledgments

Vertex Pharmaceuticals Incorporated provided funding for editorial support in the development of this manuscript; Edwin Thrower, PhD, provided editorial support and Dena McWain of Infusion Communications copyedited and styled the manuscript per journal requirements. Vertex Pharmaceuticals Incorporated reviewed and provided feedback on the manuscript to the authors. The authors had full editorial control of the manuscript and provided their final approval of all content.

\ \ 

## Author Disclosures

Nicholas J. Tustison:

Benjamin Contrella:

Talissa A. Altes:

Brian B. Avants:

Eduard E. de Lange:

John P. Mugler III:


\clearpage

# References
